1,306
Views
0
CrossRef citations to date
0
Altmetric
Women's Health

Evaluating the cost utility of estradiol plus dydrogesterone for the treatment of menopausal women in China

ORCID Icon, ORCID Icon, ORCID Icon, , , , ORCID Icon & show all
Pages 16-26 | Received 17 Oct 2023, Accepted 15 Nov 2023, Published online: 11 Dec 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.